查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1672509

2025年多重检测全球市场报告

Multiplex Assays Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年多重检测市场规模将强劲成长。到 2029 年，这一数字将成长至 54.2 亿美元，复合年增长率为 8.4%。预测期内的成长归因于资金筹措增加、政府在遗传和微生物研究方面的措施、人口老化、慢性病盛行率增加以及各种细菌和病毒传染病的激增。预测期内的主要趋势包括资金筹措增加、政府对遗传和微生物研究的措施、人口老化、慢性病盛行率增加以及各种细菌和病毒流行病的激增。

慢性病的日益普及推动了全球多重检测市场的成长。多重检测广泛应用于临床试验中，以评估疾病疗效和检测与各种疾病相关的抗体。例如，根据世界卫生组织（WHO）2023年9月发布的报告，慢性病，又称非传染性疾病（NCD），占全球死亡人数的74%，每年导致4,100万人死亡。因此，慢性病盛行率的不断上升预计将推动全球多重检测市场的需求。

预计政府和私人组织增加的资金将进一步推动多重检测市场的发展。人们正在对多重检测的开发进行大量投资，尤其是在 COVID-19 疫情带来的挑战下。 COVID-19 检测数量的激增引发了整合和併购活动。例如，2024年5月，美国生技公司Autonomous Medical Devices Incorporated（AMDI）获得美国国立卫生研究院（NIH）520万美元的津贴，用于完成其快速照护现场（POC）病毒检测系统。该系统采用聚合酵素链锁反应（PCR），这是一种备受推崇的扩增特定 DNA 序列的方法，可准确检测病毒遗传物质。该系统可以识别微量的病毒RNA和DNA，具有很高的敏感性和特异性，是早期诊断感染疾病的有用工具。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球多重分析 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球多重检测市场：成长率分析
  • 全球多重检测市场表现：规模与成长，2019-2024
  • 全球多重检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球多重分析总目标市场（TAM）

第六章市场区隔

  • 全球多重检测市场类型、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 基于蛋白质的多重检测
  • 基于核酸的多重检测
  • 其他类型
  • 全球多重检测市场（依辨识技术划分）现况及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 流式细胞技术
  • 多重即时PCR
  • 其他识别技术
  • 全球多重检测市场（按检测技术）现况及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 酵素免疫分析法（ELISA）
  • 照明
  • 萤光
  • 其他检测技术
  • 全球多重侦测市场的应用、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 研究与开发
  • 临床诊断
  • 全球多重检测市场（依最终用户、绩效及预测）2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 医院和研究机构
  • 参考实验室
  • 其他最终用户
  • 全球多重检测市场、基于蛋白质的多重检测细分市场、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • ELISA（酵素免疫分析法试验）
  • Luminex xMAP 技术
  • 蛋白质印迹法
  • 免疫组织化学
  • 基于质谱的检测
  • 全球多重检测市场：基于核酸的多重检测细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • PCR（聚合酵素链锁反应）
  • qPCR（定量PCR）
  • NGS（次世代定序）
  • 微阵列分析
  • RT-PCR（逆转录PCR）
  • 全球多重分析市场及其他细分市场，依类型、实际规模及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于细胞的多重分析
  • 生物分析检测
  • 基于成像的检测
  • 表面等离子体共振（SPR）分析

第七章 区域和国家分析

  • 全球多重检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球多重检测市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 多重检测市场：竞争格局
  • 多重分析市场：公司简介
    • Seegene Inc Overview, Products and Services, Strategy and Financial Analysis
    • DiaSorin SpA Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
    • Abcam Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • PerkinElmer Inc
  • Hologic Corporation
  • Meso Scale Diagnostics
  • Merck KGaA
  • Roche Diagnostics India Pvt Ltd
  • bioMerieux India
  • Becton Dickinson Private Limited
  • Danaher Corporation
  • Johnson & Johnson
  • Simens Healthcare
  • Beckman Coulter Inc. India
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Siemens Healthineers Ukraine
  • TestLine Clinical Diagnostics sro

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年多重检测市场：提供新机会的国家
  • 2029 年多重检测市场：细分领域蕴含新机会
  • 2029 多重检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r25804

Multiplex assays are employed to amplify multiple targets in a polymerase chain reaction (PCR) trial, enabling the extraction of additional information from minuscule amounts of proteins or other analyses in a shorter time compared to traditional systems, similar to ELISA. These assays find application in pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and other scientific endeavors.

The primary types of multiplex assays comprise nucleic acid-based multiplex assays, protein-based multiplex assays, and others. Nucleic acid-based multiplex assays rely on nucleic acids to detect organism-specific DNA or RNA sequences. These tests are generally characterized by specificity and high sensitivity, providing rapid results. Various technologies underpin multiplex assays, including flow cytometry, luminescence, fluorescence detection, multiplex real-time PCR, and other related technologies. Multiplex assays serve diverse applications, including research and development, as well as clinical diagnostics. End-users encompass pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories, and other entities involved in scientific research and diagnostics.

The multiplex assays market research report is one of a series of new reports from The Business Research Company that provides multiplex assays market statistics, including multiplex assays industry global market size, regional shares, competitors with multiplex assays market share, detailed multiplex assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex assays industry. This multiplex assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex assays market size has grown strongly in recent years. It will grow from $3.67 billion in 2024 to $3.92 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances, and a rapid growth in the aging population.

The multiplex assays market size is expected to see strong growth in the next few years. It will grow to $5.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include the rise in funding, government initiatives for genetic and microbiological research, the aging population, the increasing prevalence of chronic diseases, and a rapid rise in various bacterial and viral epidemics.

The increasing incidence of chronic diseases is fueling growth in the global multiplex assay market. Multiplex assays are widely used in clinical trials to assess disease efficacy and to detect antibodies related to various conditions. For instance, in September 2023, a report by the World Health Organization (WHO) highlighted that chronic diseases, also known as non-communicable diseases (NCDs), are responsible for 74% of global deaths, amounting to 41 million fatalities annually. Consequently, the growing prevalence of chronic diseases is expected to drive demand in the global multiplex assay market.

The market for multiplex assays is expected to be further driven by increased funding from governments and private organizations. Significant investments are being made to develop multiplex assays, especially amid the challenges posed by the COVID-19 pandemic. The surge in COVID-19 testing has led to consolidation and merger activities. For instance, in May 2024, Autonomous Medical Devices Incorporated (AMDI), a U.S.-based biotechnology company, received a $5.2 million grant from the National Institutes of Health (NIH) to finalize its rapid point-of-care (POC) viral testing system. This system employs polymerase chain reaction (PCR), a highly regarded method for amplifying specific DNA sequences, enabling accurate detection of viral genetic material. With its capability to identify even minimal amounts of viral RNA or DNA, the system offers high sensitivity and specificity, making it a valuable tool for diagnosing infections at their early stages.

Companies in the market are actively launching innovative tests based on multiplex assays to fortify their market positions. In May 2022, QuantuMDx Group Limited introduced the Q-POC SARS-CoV-2, Flu A/B, and RSV Assay, a multiplex panel designed to detect SARS-CoV-2, Influenza A, Influenza B, and RSV at the point of need, further showcasing the market's evolution.

Companies in the multiplex assay market are prioritizing new product launches to enhance their market presence. For example, in January 2024, Bio-Rad Laboratories Inc., a U.S.-based company specializing in life science research and clinical diagnostic products, introduced the ddPLEX ESR1 Mutation Detection Kit. This kit is the first ultrasensitive multiplexed digital PCR assay designed specifically for detecting breast cancer mutations in clinical research. It allows for the simultaneous detection and quantification of seven relevant ESR1 mutations in a single well, simplifying the testing process. With an analytical sensitivity of 0.01% variant allele fraction (VAF), it can detect low-frequency mutations, which are crucial in cancer diagnostics. Additionally, the kit is compatible with circulating tumor DNA (ctDNA) from plasma and DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples, offering flexibility in sample types for testing.

In May 2022, CellCarta, a Canada-based precision laboratory services company, acquired Precision Assays for an undisclosed amount. This acquisition aims to expand CellCarta's precision medicine laboratory services by obtaining commercial rights to antibody panels and assays developed by Precision Assays. Through this acquisition, CellCarta enhances its capabilities in next-generation targeted proteomics testing solutions, especially benefiting its pharmaceutical and biotech clients. Precision Assays, a U.S.-based developer, specializes in high-end multiplex quantitative immuno-MRM mass spectrometry-based assays, adding advanced analytical capabilities to CellCarta's service offerings.

Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMerieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The multiplex assays market consists of sales of equipment with technologies that can detect multiple genes such as flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies in multiplex assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiplex assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types
  • 2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies
  • 3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies
  • 4) By Application: Research And Development, Clinical Diagnostics
  • 5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users
  • Subsegments:
  • 1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay); Luminex xMAP Technology; Western Blotting; Immunohistochemistry; Mass Spectrometry-Based Assays
  • 2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction); qPCR (Quantitative PCR); NGS (Next-Generation Sequencing); Microarray Analysis; RT-PCR (Reverse Transcription PCR)
  • 3) By Other Types: Cell-Based Multiplex Assays; Bioanalytical Assays; Imaging-Based Assays; Surface Plasmon Resonance (SPR) Assays
  • Companies Mentioned: Seegene Inc; DiaSorin SpA; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; Abcam Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex Assays Market Characteristics

3. Multiplex Assays Market Trends And Strategies

4. Multiplex Assays Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Multiplex Assays Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Multiplex Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Multiplex Assays Market Growth Rate Analysis
  • 5.4. Global Multiplex Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Multiplex Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Multiplex Assays Total Addressable Market (TAM)

6. Multiplex Assays Market Segmentation

  • 6.1. Global Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Protein-Based Multiplex Assays
  • Nucleic Acid-Based Multiplex Assays
  • Other Types
  • 6.2. Global Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flow Cytometry
  • Multiplex Real-Time PCR
  • Other Identification Technologies
  • 6.3. Global Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Luminescence
  • Fluorescence
  • Other Detection Technologies
  • 6.4. Global Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research And Development
  • Clinical Diagnostics
  • 6.5. Global Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Research Institutes
  • Reference Laboratories
  • Other End-Users
  • 6.6. Global Multiplex Assays Market, Sub-Segmentation Of Protein-Based Multiplex Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Luminex xMAP Technology
  • Western Blotting
  • Immunohistochemistry
  • Mass Spectrometry-Based Assays
  • 6.7. Global Multiplex Assays Market, Sub-Segmentation Of Nucleic Acid-Based Multiplex Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR (Polymerase Chain Reaction)
  • qPCR (Quantitative PCR)
  • NGS (Next-Generation Sequencing)
  • Microarray Analysis
  • RT-PCR (Reverse Transcription PCR)
  • 6.8. Global Multiplex Assays Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell-Based Multiplex Assays
  • Bioanalytical Assays
  • Imaging-Based Assays
  • Surface Plasmon Resonance (SPR) Assays

7. Multiplex Assays Market Regional And Country Analysis

  • 7.1. Global Multiplex Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Multiplex Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiplex Assays Market

  • 8.1. Asia-Pacific Multiplex Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiplex Assays Market

  • 9.1. China Multiplex Assays Market Overview
  • 9.2. China Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiplex Assays Market

  • 10.1. India Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiplex Assays Market

  • 11.1. Japan Multiplex Assays Market Overview
  • 11.2. Japan Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiplex Assays Market

  • 12.1. Australia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiplex Assays Market

  • 13.1. Indonesia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiplex Assays Market

  • 14.1. South Korea Multiplex Assays Market Overview
  • 14.2. South Korea Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiplex Assays Market

  • 15.1. Western Europe Multiplex Assays Market Overview
  • 15.2. Western Europe Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiplex Assays Market

  • 16.1. UK Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiplex Assays Market

  • 17.1. Germany Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiplex Assays Market

  • 18.1. France Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiplex Assays Market

  • 19.1. Italy Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiplex Assays Market

  • 20.1. Spain Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiplex Assays Market

  • 21.1. Eastern Europe Multiplex Assays Market Overview
  • 21.2. Eastern Europe Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiplex Assays Market

  • 22.1. Russia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiplex Assays Market

  • 23.1. North America Multiplex Assays Market Overview
  • 23.2. North America Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiplex Assays Market

  • 24.1. USA Multiplex Assays Market Overview
  • 24.2. USA Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiplex Assays Market

  • 25.1. Canada Multiplex Assays Market Overview
  • 25.2. Canada Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiplex Assays Market

  • 26.1. South America Multiplex Assays Market Overview
  • 26.2. South America Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiplex Assays Market

  • 27.1. Brazil Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiplex Assays Market

  • 28.1. Middle East Multiplex Assays Market Overview
  • 28.2. Middle East Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiplex Assays Market

  • 29.1. Africa Multiplex Assays Market Overview
  • 29.2. Africa Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Multiplex Assays Market, Segmentation By Detection Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiplex Assays Market Competitive Landscape And Company Profiles

  • 30.1. Multiplex Assays Market Competitive Landscape
  • 30.2. Multiplex Assays Market Company Profiles
    • 30.2.1. Seegene Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. DiaSorin SpA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abcam Plc Overview, Products and Services, Strategy and Financial Analysis

31. Multiplex Assays Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc
  • 31.2. Hologic Corporation
  • 31.3. Meso Scale Diagnostics
  • 31.4. Merck KGaA
  • 31.5. Roche Diagnostics India Pvt Ltd
  • 31.6. bioMerieux India
  • 31.7. Becton Dickinson Private Limited
  • 31.8. Danaher Corporation
  • 31.9. Johnson & Johnson
  • 31.10. Simens Healthcare
  • 31.11. Beckman Coulter Inc. India
  • 31.12. Ortho Clinical Diagnostics
  • 31.13. Sysmex Corporation
  • 31.14. Siemens Healthineers Ukraine
  • 31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Multiplex Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiplex Assays Market

34. Recent Developments In The Multiplex Assays Market

35. Multiplex Assays Market High Potential Countries, Segments and Strategies

  • 35.1 Multiplex Assays Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Multiplex Assays Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Multiplex Assays Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer